TCF4 and neoplasm: Li [126] found that MDSCs in contact with tumor cells can enhance the expression of Cyclooxygenase-2 (COX-2) in tumor cells, activate the β-catenin/TCF4 pathway, and promote the occurrence of EMT in tumor cells.